Investors tracking the AI infrastructure buildout are turning attention to smaller specialists in photonics and optical technology beyond the biggest chip names. Aeluma (ALMU) and POET Technologies (POET) both occupy this niche, yet they present quite different risk-and-reward profiles. This comparison examines their business models, recent results, growth drivers, and market positions. It should prove useful for growth-oriented traders following semiconductor themes, optical interconnects, and emerging AI hardware who are comfortable assessing early-stage, pre-profit companies.
Aeluma, Inc. (ALMU) is a California-based semiconductor company focused on high-performance, scalable compound semiconductor and photonics technology. Its platform addresses applications in artificial intelligence, defense and aerospace, mobile devices, robotics, automotive, AR/VR, and quantum computing. The company balances commercial partnerships with government R&D contracts, which helps diversify its revenue streams relative to many peers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recently, Aeluma has emphasized scaling wafer production and advancing commercialization efforts, including strategic appointments and investor conference participation. The company reported modest trailing revenue of roughly $4.5 million alongside a net loss, consistent with its pre-commercial stage. Its share price has retreated from the 52-week high and trades below recent moving averages. Still, the two analysts covering the stock maintain a "Strong Buy" consensus with a price target well above current levels, reflecting confidence in its longer-term technology positioning.
POET Technologies Inc. (POET) is a Toronto-headquartered developer of photonic integrated circuits and optical interconnects. Its core Optical Interposer technology integrates electronic and photonic components onto a single chip via wafer-level manufacturing, aimed at AI data center connectivity and optical networking. The company has delivered six consecutive quarters of sequential revenue growth, with recent quarterly revenue more than doubling year over year.
Market activity for POET has been volatile. The company secured a $50 million purchase order from Lumilens that could scale toward $500 million over five years, though this followed cancellation of a previously announced Marvell-related order. It also raised substantial capital through share issuance and maintains a large cash and short-term investments balance, though warrants and prior dilution warrant attention. The stock has fallen sharply from its 52-week high and trades below both its 20-day and 60-day moving averages, with ongoing securities litigation adding to the risk profile.
While both firms work in photonics and AI hardware, their positioning differs. Aeluma (ALMU) is a smaller, more diversified player with exposure to defense, mobile, and sensing applications alongside AI, supported by government contracts that provide non-dilutive funding. Its market capitalization is modest, yet its capital structure is cleaner and analyst consensus remains strongly positive. POET Technologies (POET), by contrast, offers a larger-cap, AI-data-center-focused opportunity with faster revenue growth, a much larger cash balance, and a potentially significant supply agreement, offset by dilution, a canceled order, and litigation overhangs.
On momentum, both stocks have pulled back from highs and sit below key moving averages, indicating neither is in a confirmed uptrend at present. POET's price swings have been more pronounced, influenced by headlines and sector-wide optical selloffs, whereas Aeluma's moves have been steadier. Risk factors also vary: POET contends with concentration and financing risks, while Aeluma faces typical execution and commercialization challenges of an early-stage semiconductor developer. Investors seeking stability and diversified end-markets may prefer Aeluma's measured profile; those pursuing higher-beta exposure to AI photonics growth may view POET as offering greater volatility alongside opportunity.
Based on factors such as trend consistency, stability, catalyst quality, and relative positioning, the AI analysis currently favors ALMU over POET. Aeluma's diversified revenue base, stronger analyst consensus, cleaner balance sheet, and reduced headline-driven volatility point to a comparatively more stable setup, even with its smaller absolute revenue. POET's superior growth rate and sizable cash position stand out as strengths, yet dilution, litigation overhang, and order disruptions introduce greater uncertainty. This view reflects a probabilistic, trend-based assessment of current conditions rather than a firm prediction, and relative positioning may evolve with new earnings and order data.
When evaluating setups like these, I often turn to Tickeron's Trending AI Robots to review algorithmic strategies that align with current market conditions. The page highlights a curated selection of AI trading bots, each with distinct styles, timeframes, win rates, and performance histories. This helps match approaches to individual risk tolerance without needing to build strategies from scratch.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
On October 28, 2026, the Stochastic Oscillator for POET moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 73 instances where the indicator left the oversold zone. In 61 of the 73 cases the stock moved higher in the following days. This puts the odds of a move higher at over 84%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where POET's RSI Oscillator exited the oversold zone, 18 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for POET just turned positive on October 29, 2026. Looking at past instances where POET's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
Following a +8.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where POET advanced for three days, in 191 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
POET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on POET as a result. In 73 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where POET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for POET entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. POET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.156) is normal, around the industry mean (6.493). P/E Ratio (-8.203) is within average values for comparable stocks, (21.736). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. POET's P/S Ratio (769.231) is very high in comparison to the industry average of (45.794).
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors